Search Results - "Einarsdóttir, Rannveig"

Continuous increase of immunoglobulin therapy in Iceland by Runólfsson, Valgeir Steinn, Lúdvíksson, Björn Rúnar, Einarsdóttir, Rannveig, Óskarsdóttir, Þórunn, Thors, Valtýr, Haraldsson, Ásgeir

“…Background: The use of immunoglobulin treatment has been increasing for various indications. The objective of this study was to evaluate clinical use of…”
Get full text

Approved and unapproved use of immunoglobulins in Iceland by Ólafsdóttir, Bryndís Ester, BSc, Þorsteinsson, Davíð Þór, MD, Einarsdóttir, Rannveig, MSc, Lúðvíksson, Björn Rúnar, MD, PhD, Gröndal, Gerður, MD, Erlendsson, Kristján, MD, Haraldsson, Ásgeir, MD, PhD

“…To the Editor: Immunoglobulin therapy has been increasingly used in the treatment of various diseases for decades.1-5 Congenital or acquired immunodeficiency,…”
Get full text

Clinical consequences following regulatory changes in respect to reimbursement of statins cost by the Icelandic Social Insurance Administration by GIZURARSON, SVEINBJÖRN, BJÖRNSDÓTTIR, LINDA RÓS, EINARSDÓTTIR, RANNVEIG, HALLDÓRSSON, MATTHÍAS, ANDERSEN, KARL

“…Introduction: On 1 March 2009, a new reimbursement system was introduced by the Ministry of Health of Iceland regarding drugs to treat hyperlipidaemia. The…”
Get full text

Risk Factors for Clostridium difficile Toxin Positive Diarrhea, a Population Based Prospective Case Control Study by Vesteinsdottir, Iris, Einarsdottir, Rannveig A, Gudlaugsdottir, Sunna, Jonasdottir, Alda, Bjornsson, Einar

Get full text

The Expiry of Humira ® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures by Moorkens, Evelien, Godman, Brian, Huys, Isabelle, Hoxha, Iris, Malaj, Admir, Keuerleber, Simon, Stockinger, Silvia, Mörtenhuber, Sarah, Dimitrova, Maria, Tachkov, Konstantin, Vončina, Luka, Palčevski, Vera Vlahović, Achniotou, Gnosia, Slabý, Juraj, Popelková, Leona, Kohoutová, Kateřina, Bartels, Dorthe, Laius, Ott, Martikainen, Jaana E, Selke, Gisbert W, Kourafalos, Vasileios, Magnússon, Einar, Einarsdóttir, Rannveig, Adams, Roisín, Joppi, Roberta, Allocati, Eleonora, Jakupi, Arianit, Viksna, Anita, Greičiūtė-Kuprijanov, Ieva, Vella Bonanno, Patricia, Suttorp, Vincent, Melien, Øyvind, Plisko, Robert, Mardare, Ileana, Meshkov, Dmitry, Novakovic, Tanja, Fürst, Jurij, Zara, Corinne, Marković-Peković, Vanda, Grubiša, Nataša, Befrits, Gustaf, Puckett, Robert, Vulto, Arnold G

“…From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the…”
Get full text

Efficacy of diphenhydramine against cough in humans: a review by Björnsdóttir, Ingunn, Einarson, Thomas Ray, Gudmundsson, Lárus Steinpór, Einarsdóttir, Rannveig Alma

“…To determine the efficacy of diphenhydramine against cough due to respiratory infection or irritation in patients/subjects without comorbidities. Two reviewers…”
Get more information

Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists by Björnsson, Einar S, Gunnarsson, Baldvin I, Gröndal, Gerdur, Jonasson, Jon G, Einarsdottir, Rannveig, Ludviksson, Björn R, Gudbjörnsson, Björn, Olafsson, Sigurdur

“…Background & Aims Antagonists of tumor necrosis factor (anti-TNF agents) can cause drug-induced liver injury (DILI), yet little is known about the level of…”
Get full text

Discrepancies in Liver Disease Labeling in the Package Inserts of Commonly Prescribed Medications by Bjornsson, Einar S, Jacobsen, Elin I, Einarsdottir, Rannveig, Chalasani, Naga

Get full text

Mo1993 Little Evidence for Serious Outcome in Patients With Chronic Liver Disease Receiving Potentially Hepatotoxic Drugs by Bjornsson, Einar, Einarsdottir, Rannveig, Jacobsen, Elin, Chalasani, Naga P

Get full text

384 The Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor (TNF)-a Antagonists by Gunnarsson, Baldvin I, Grondal, Gerdur, Ludviksson, Bjorn R, Einarsdottir, Rannveig, Olafsson, Sigurdur, Jonasson, Jon G, Bjornsson, Einar

Get full text

Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study by Gudbjornsson, Bjorn, Thorsteinsson, Sigurdur B, Sigvaldason, Helgi, Einarsdottir, Rannveig, Johannsson, Magnus, Zoega, Helga, Halldorsson, Matthias, Thorgeirsson, Gudmundur

“…Purpose To examine the risk of thromboembolic cardiovascular events in users of coxibs and NSAIDs in a nationwide cohort. Methods Data were synchronised from…”
Get full text